Navigation Links
Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCath's Board of Directors
Date:4/7/2008

CHARLOTTE, N.C., April 7, 2008 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH) announced today that Pamela G. Bailey and Edward R. Casas have been appointed to its Board of Directors.

Ms. Bailey, currently President and Chief Executive Officer for Personal Care Products Council, brings significant leadership and health care policy experience to the MedCath Board of Directors. She has served as President and Chief Executive Officer of Advanced Medical Technology Association, a Washington, D.C.-based trade association and the largest medical technology association in the world. In addition, she was founding Chief Executive Officer and President of Healthcare Leadership Council, an association of over 50 health care industry chief executives, and served as President of National Committee for Quality Health Care, a leader and advocate for market-based health care reforms in the national health care debates of the 1990s. She also served in the White House for three United States Presidents: Ronald Reagan, Gerald Ford and Richard Nixon.

Dr. Casas, currently Managing Director and Co-Head of Navigant Capital Advisors, brings considerable financial and capital markets experience and knowledge to the MedCath Board of Directors. He currently oversees the Investment Banking, Restructuring, Valuation and Transaction Services practice areas that provide advisory support for Navigant clients. He served as a member of Navigant Consulting, Inc.'s (NYSE: NCI) Senior Management Committee. Previously, he was a founding Member and Senior Managing Director of Casas, Benjamin & While, LLC, a leading boutique mergers, acquisitions, private equity and financial restructuring firm. He also served as President and Chief Executive Officer of PrimeCare International, Inc. and as Vice President, Mergers and Acquisitions, for Caremark International, Inc. He served in the United States Navy, U.S. Marine Corps. as a Flight Surgeon.

"We are extremely pleased to add the experience and leadership of Ms. Bailey and Dr. Casas to our Board of Directors," said Board Chairman John Casey. "They each possess considerable qualities and attributes that make them ideal directors for MedCath. I welcome them to the Board."

The new board members will begin serving immediately. Also, Edward A. Gilhuly has retired from the board. Mr. Gilhuly has been a director since August 1998. In January 2006, Mr. Gilhuly became a member of Sageview Capital LLC. Prior to that, he was an executive of Kohlberg Kravis Roberts and Co., L.P. and a general partner from January 1995, before becoming a member of the limited liability company which serves as the general partner of KKR in January 1996. Mr. Gilhuly was managing director of Kohlberg Kravis Roberts & Co. Ltd., the London-based affiliate of KKR, prior to forming Sageview.

"Mr. Gilhuly has helped MedCath grow considerably during his nearly 10 years on the Board, and we are incredibly grateful for the insight and leadership he provided," Casey said.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns interests in and operates ten hospitals with a total of 663 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.


'/>"/>
SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan
2. Statement by John Bailey, EVP for Science Cosmetic, Toiletry, and Fragrance Association on Campaign for Safe Cosmetics Report on Lead in Lipstick
3. Edwards Lifesciences Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan
4. Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference
5. Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference
6. Statement by Dr. Edward Jones, Chairman of Kidney Care Partners in Response to CMS Payment Bundling Report
7. Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
8. Edwards Lifesciences Reports Strong Fourth Quarter Sales
9. ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors
10. Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard
11. Edward Hospital Statement Regarding Indictment of P. Nicholas Hurtgen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... Vitenas Cosmetic Surgery has been named as ... the American Institute of Architects and the Academy of Architecture for Health. The building, ... Harrell Architects, opened to patients in October of 2014. , The ...
(Date:5/5/2016)... , ... May 05, 2016 , ... TIME for Kids ... – today announced a new partnership to reach nearly 1 million children with important ... an instant and is the leading cause of accidental death in children one to ...
(Date:5/5/2016)... ... May 05, 2016 , ... In order to increase ... patterns, Amerec, a Seattle-based steam bath and sauna manufacturer recently launched amerecConnect™ ... interface of the app, developed for both smartphones and personal computers perfectly emulates ...
(Date:5/5/2016)... ... (PRWEB) May 05, 2016 , ... Talent Tech Labs (TTL) is ... eve of National Nurses Week (May 6-12). Currently, HireNurses is a job ... enrollment into the Talent Tech Lab Virtual Incubation program, they will dramatically expand the ...
(Date:5/5/2016)... ... ... Chronic stress can have a silent, yet dangerous, impact on men’s heart health. ... inflammation, both of which raise the risk of heart attack and even stroke,” says ... Massachusetts General Hospital. Chronic stress also can lead to other issues that indirectly affect ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Israel , May 4, 2016 ... today that BiondVax,s CEO, Dr. Ron Babecoff , will ... New York City . On Thursday, ... Pioneers 2016, a conference presented by Joseph Gunner ... The BiondVax presentation that Dr. Babecoff will be ...
(Date:5/4/2016)... Yissum Research Development Company of the ... had signed an exclusive world-wide licensing and research agreement ... degradation and immunomodulatory drugs for cancer and immune dysfunction, ... first-in-class therapy for hematologic and solid malignancies. Financial terms ... novel technology was developed by Yinon Ben-Neriah , ...
(Date:5/4/2016)... 4, 2016 Valeritas Holdings, Inc. ... alternative public offering (APO). This was accomplished via a ... Inc. and a private placement of approximately 5 million ... share. Under the terms of the reverse ... Holdings, Inc. will trade on the OTC Markets under ...
Breaking Medicine Technology: